FDA AdCom panel to review and vote on next COVID shots
Source: SeekingAlpha
2026-05-26 11:49:42 ET
More on Pfizer, Moderna, etc.
- Pfizer: Reduced TrumpRx/Patent Risks Meet Accretive M&A Efforts - Reiterate Buy
- FQ1 Healthcare Dividend Roundup: Johnson & Johnson Keeps Outshining Pfizer
- Moderna, Inc. (MRNA) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
- BridgeBio downgraded at Raymond James on LOE for Pfizer’s Vyndamax
- Moderna to face FDA AdCom review for flu shot
Read the full article on Seeking Alpha
For further details see:
FDA AdCom panel to review and vote on next COVID shots
Sanofi
NASDAQ: SNY
SNY Trading
1.75% G/L:
$45.035 Last:
1,382,086 Volume:
$45 Open:
SNY Latest News
June 03, 2026 09:13:54 am
Sanofi aims to cut AI-driven drug development timelines in half with Snowflake
SNY Stock Data
$119,804,457,217
2,430,957,423
N/A
389
N/A
Pharmaceuticals
Healthcare
FR
Paris
